Patents by Inventor Henrik Egesborg
Henrik Egesborg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10016134Abstract: A portable medical device for communication of medical data information has a medical device part that includes a first processor and first storage means, and means for executing one or more medical related functions, a communication device part comprising a second processor, second storage means, and communication means. The medical device part and the communication device part are connected allowing for exchange of data information according to a predetermined protocol. The exchange of communication may be under the control of the medical device part, but the functionalities of each device part otherwise is separated providing for easy interchangeability of the communication device part or the medical device part. Also disclosed is a method for communication of medical data information.Type: GrantFiled: June 8, 2010Date of Patent: July 10, 2018Assignee: Novo Nordisk A/SInventors: Henrik Egesborg Hansen, Michael Eilersen, Niels Pryds Rolsted
-
Patent number: 9848805Abstract: A new biostable glucose permeable polymer has been developed which is useful, for example, in implantable glucose sensors. This biostable glucose permeable polymer has a number of advantageous characteristics and, for example, does not undergo hydrolytic cleavage and degradation, thereby providing a composition that facilitates long term sensor stability in vivo. The versatile characteristics of this polymer allow it to be used in a variety of contexts, for example to form the body of an implantable glucose sensor. The invention includes the polymer composition, sensor systems formed from this polymer composition, and methods for making and using such sensor systems.Type: GrantFiled: December 18, 2015Date of Patent: December 26, 2017Assignee: Medtronic MiniMed, Inc.Inventors: Tri T. Dang, Henrik Egesborg, Jakob Janting, Rajiv Shah, Daniel Aaskov, Joseph F. Hall, Soren Aasmul
-
Publication number: 20170312342Abstract: The present invention relates a pharmaceutical formulation comprising a long-acting growth hormone for use in a method of treating growth hormone deficiency, wherein the long-acting growth hormone formulation is administered to a patient in a bracketed dosage regimen, to a multitude of unit dosage forms comprising a long-acting growth hormone formulation, wherein the unit dosage forms comprise increasing amounts of growth hormone equivalents and wherein the amount of growth hormone equivalents increases by at least 10% between one unit dosage form and the next higher dosage form; their use in a method of treating growth hormone deficiency and method of treating growth hormone deficiency in a bracketed dosing regimen.Type: ApplicationFiled: November 20, 2015Publication date: November 2, 2017Applicant: Ascendis Pharma Endocrinology Division A/SInventors: Kennett Sprogøe, Henrik Egesborg, Steen Jennsen, Thomas Kurpiers
-
Publication number: 20170172471Abstract: A new biostable glucose permeable polymer has been developed which is useful, for example, in implantable glucose sensors. This biostable glucose permeable polymer has a number of advantageous characteristics and, for example, does not undergo hydrolytic cleavage and degradation, thereby providing a composition that facilitates long term sensor stability in vivo. The versatile characteristics of this polymer allow it to be used in a variety of contexts, for example to form the body of an implantable glucose sensor. The invention includes the polymer composition, sensor systems formed from this polymer composition, and methods for making and using such sensor systems.Type: ApplicationFiled: December 18, 2015Publication date: June 22, 2017Applicant: Medtronic MiniMed, Inc.Inventors: Tri T. Dang, Henrik Egesborg, Jakob Janting, Rajiv Shah, Daniel Aaskov, Joseph F. Hall, Soren Aasmul
-
Patent number: 8454997Abstract: A solid pharmaceutical composition for parenteral administration having an inner matrix containing at least one therapeutic agent, and a biodegradable, and water-impermeable coating covering part of the surface of said composition. The inner matrix disintegrates upon contact with animal tissue or tissue fluids. By providing a disintegratable and/or soluble inner matrix comprising the drug with a water-impermeable coating covering part of the surface of said composition, the rate of release of the drug can be controlled. The specific rate of release can be controlled by carefully designing the part of the surface which is not covered.Type: GrantFiled: December 18, 2002Date of Patent: June 4, 2013Assignee: Novo Nordisk A/SInventors: Henrik Egesborg Hansen, Thomas Buch-Rasmussen, Mads Christian Sabra
-
Publication number: 20100250697Abstract: A portable medical device for communication of medical data information has a medical device part that includes a first processor and first storage means, and means for executing one or more medical related functions, a communication device part comprising a second processor, second storage means, and communication means. The medical device part and the communication device part are connected allowing for exchange of data information according to a predetermined protocol. The exchange of communication may be under the control of the medical device part, but the functionalities of each device part otherwise is separated providing for easy interchangeability of the communication device part or the medical device part. Also disclosed is a method for communication of medical data information.Type: ApplicationFiled: June 8, 2010Publication date: September 30, 2010Applicant: Novo Nordisk A/SInventors: HENRIK EGESBORG HANSEN, Michael Eilersen, Niels Pryds Rolsted
-
Publication number: 20080228057Abstract: Disclosed is a method and system of controlling data information between two portable handheld apparatuses where the portable apparatuses include a first apparatus for performing a first operation and a second operation, and a second apparatus including a drug administration device.Type: ApplicationFiled: March 19, 2008Publication date: September 18, 2008Applicant: Novo Nordisk A/SInventors: Henning Graskov, Henrik Egesborg Hansen, Michael Eilersen, Steffen Lav
-
Publication number: 20080177155Abstract: A portable medical device for communication of medical data information has a medical device part that includes a first processor and first storage means, and means for executing one or more medical related functions, a communication device part comprising a second processor, second storage means, and communication means. The medical device part and the communication device part are connected allowing for exchange of data information according to a predetermined protocol. The exchange of communication may be under the control of the medical device part, but the functionalities of each device part otherwise is separated. Also disclosed is a method for communication of medical data information.Type: ApplicationFiled: January 22, 2008Publication date: July 24, 2008Applicant: Novo Nordisk A/SInventors: Henrik Egesborg Hansen, Michael Eilersen, Niels Pryds Rolsted
-
Publication number: 20080177154Abstract: A portable medical device for communication of medical data information has a medical device part that includes a first processor and first storage means, and means for executing one or more medical related functions, a communication device part comprising a second processor, second storage means, and communication means. The medical device part and the communication device part are connected allowing for exchange of data information according to a predetermined protocol. The exchange of communication may be under the control of the medical device part, but the functionalities of each device part otherwise is separated providing for easy interchangeability of the communication device part or the medical device part. Also disclosed is a method for communication of medical data information.Type: ApplicationFiled: January 22, 2008Publication date: July 24, 2008Applicant: Novo Nordisk A/SInventors: Henrik Egesborg Hansen, Michael Eilersen, Niels Pryds Rolsted
-
Publication number: 20040199127Abstract: A method and a system is provided for producing a needle of plastic, as well as a needle of plastic, in particular a needle for medical purposes. The method produces a needle having at least the outer diameter of one end being less than 0.50 mm using a moulding system having an assembly comprising a feed system and a mould cavity. The method includes introducing a melt of plastic into the feed system, increasing the melt pressure gradually during melt passage through the feed system, passing the melt into the mould cavity whereby the melt substantially fills the mould cavity, cooling the melt in the mould cavity whereby the melt solidifies to a needle, and removing the needle from the mould cavity.Type: ApplicationFiled: April 26, 2004Publication date: October 7, 2004Inventors: Soren Jensen, Mogens Papsoe, Poul E. B. Nielsen, Henrik Egesborg Hansen, Anne Sorensen
-
Patent number: 6767496Abstract: A method and a system is provided for producing a needle of plastic, as well as the needle of plastic which includes a needle for medical purposes. The method for producing the needle includes introducing a melt of plastic into a feed system, increasing the melt pressure gradually during melt passage through the feed system, passing the melt into the mould cavity, whereby the melt substantially fills the mould cavity, cooling the melt into the mould cavity whereby the melt solidifies to a needle, and removing the needle from the mould cavity. Increasing the pressure through the feed system provides for meeting specific pressure demands at the entrance of the mould cavity, thereby moulding thin and elongated articles.Type: GrantFiled: November 27, 2001Date of Patent: July 27, 2004Assignee: Novo Nordisk A/SInventors: Søren Jensen, Mogens Papsøe, Poul E. B. Nielsen, Henrik Egesborg Hansen, Anne Sørensen
-
Publication number: 20030161881Abstract: A solid pharmaceutical composition for parenteral administration having an inner matrix containing at least one therapeutic agent, and a biodegradable, and water-impermeable coating covering part of the surface of said composition. The inner matrix disintegrates upon contact with animal tissue or tissue fluids. By providing a disintegratable and/or soluble inner matrix comprising the drug with a water-impermeable coating covering part of the surface of said composition, the rate of release of the drug can be controlled. The specific rate of release can be controlled by carefully designing the part of the surface which is not covered.Type: ApplicationFiled: December 18, 2002Publication date: August 28, 2003Inventors: Henrik Egesborg Hansen, Thomas Buch-Rasmussen, Mads Christian Sabra
-
Publication number: 20030065536Abstract: A portable medical device for communication of medical data information has a medical device part that includes a first processor and first storage means, and means for executing one or more medical related functions, a communication device part comprising a second processor, second storage means, and communication means. The medical device part and the communication device part are connected allowing for exchange of data information according to a predetermined protocol. The exchange of communication may be under the control of the medical device part, but the functionalities of each device part otherwise is separated. Also disclosed is a method for communication of medical data information.Type: ApplicationFiled: August 7, 2002Publication date: April 3, 2003Inventors: Henrik Egesborg Hansen, Michael Eilersen, Niels Pryds Rolsted
-
Patent number: 6277098Abstract: An injection device has signal generators (11, 12, 13, 14) which are connected to operative elements (8, 3, 5, 4) of the device and which give off signals which represents the operative condition of the device. The signals are sent to an electronic circuit which controls a presentation of the operational condition of the device and presents operational conditions, which are defined as not allowed, as error indications by switching off the display presenting the operational condition of the device. The number of signals from each generator is counted and a number of operations exceeding a pre-set number for the signal generator in question is interpreted as representing a not allowed operational condition.Type: GrantFiled: December 8, 1997Date of Patent: August 21, 2001Assignee: Novo Nordisk A/SInventors: Lars Peter Klitmose, Henrik Egesborg Hansen
-
Patent number: 5680858Abstract: A method for in vivo determination of the concentration in a body fluid of metabolically significant substance comprises storing of a needle with a sensor in a liquid-filled ampoule, brief insertion of the needle into a patient, recording of the output signal from the sensor, withdrawal of the needle, and calculation of the concentration looked for on the basis of the recorded signals. The method is preformed using an apparatus comprising a needle (5) with a sensor (6), an ampoule (1) containing a solution (2) and closed by two membranes (3, 4). The needle (5) is stored with its sensor (6) in the solution. The apparatus further comprises a mechanical unit for driving the needle (5) to protrude from the ampoule for a set moment, and an electronic unit storing the output signal from the sensor (6) and performing calculations on the basis of the stored signal values.Type: GrantFiled: July 6, 1995Date of Patent: October 28, 1997Assignee: Novo Nordisk A/SInventors: Henrik-Egesborg Hansen, Henrik Ege, Thomas Munk Plum